镥-177-PSMA治疗中辐射剂量学方案的优化:走向临床实施
本研究纳入10例转移性激素敏感性前列腺癌患者,每例接受两周期[177Lu]Lu-PSMA-617治疗,以5时间点SPECT剂量学为参考标准,比较简化方案的吸收剂量不确定性。结果显示病灶剂量学可用168小时单时间点SPECT完成但不确定性增加,加第二时间点后与参考标准相当;器官剂量学可用24小时或48小时单次SPECT完成;基于平面扫描的剂量学不能提供准确剂量估算。
要点
- 病灶剂量学可用168小时单时间点SPECT完成,不确定性20% vs 参考标准14%。
- 加入第二时间点后不确定性13%,与参考标准相当。
- 器官剂量学可用24小时或48小时单次SPECT完成,平面扫描不能准确估算剂量。
核心结论
- [177Lu]Lu-PSMA治疗中准确的病灶剂量学可用单时间点或双时间点方案完成,使剂量学评估更适合常规临床实施,尽管多时间点剂量学更准确。
研究设计与样本
- 10例转移性激素敏感性前列腺癌患者接受两周期[177Lu]Lu-PSMA-617治疗,于1、24、48、72和168小时行三床位SPECT/CT及全身平面扫描,以5时间点SPECT剂量学为参考标准。
主要发现
- 病灶剂量学用168小时单时间点SPECT可行,不确定性20% vs 参考标准14%。
- 加入第二时间点后不确定性13%,与参考标准相当。
- 器官剂量学可用24小时或48小时单次SPECT完成。
- 基于平面扫描的剂量学不能提供准确的剂量估算。
关键数值与推荐
- 病灶剂量学单时间点方案不确定性20%,参考标准为14%。
- 病灶剂量学双时间点方案不确定性13%。
- 器官剂量学单次SPECT时间点为24小时或48小时。
临床怎么用
- 作者认为[177Lu]Lu-PSMA治疗中准确的病灶剂量学可用单时间点或双时间点方案完成,使剂量学评估更适合常规临床实施,尽管多时间点剂量学更准确。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dosimetry in [177Lu]Lu-PSMA therapy is a valuable tool to assess treatment efficacy and toxicity. This study aims to develop a clinically implementable protocol to determine the absorbed dose in organs and tumor lesions after [177Lu]Lu-PSMA-617 therapy, by reducing the imaging time points and utilizing population-based kinetics with a single scan, with evaluation of its influence on the uncertainty in absorbed dose. METHODS: Ten patients with metastatic hormone-sensitive prostate cancer received two cycles of [177Lu]Lu-PSMA-617. Post-treatment imaging was performed at 1 h, 24 h, 48 h, 72 h and 168 h, consisting of three-bed positions SPECT/CT and a whole-body planar scan. Five-time point SPECT dosimetry was performed for lesions and organs with physiological uptake (kidneys, liver and salivary glands) and used as the reference standard. Absorbed dose values for various simplified protocols were compared to the reference standard. RESULTS: Accurate lesion dosimetry is possible using one-time point SPECT imaging at 168 h, with an increase in uncertainty (20% vs. 14% for the reference standard). By including a second time point, uncertainty was comparable to the reference standard (13%). Organ dosimetry can be performed using a single SPECT at 24 h or 48 h. Dosimetry based on planar scans did not provide accurate dose estimations. CONCLUSION: Accurate lesion dosimetry in [177Lu]Lu-PSMA therapy can be performed using a one- or two-time point protocol, making dosimetry assessments more suitable for routine clinical implementation, although dosimetry based om multiple time points is more accurate. Clinical trial registration This study was approved by the Medical Review Ethics Committee Region Arnhem-Nijmegen on January 23, 2018 and was registered on clinicaltrials.gov (NCT03828838).
引用
- Peters SMB, Mink MCT, Privé BM, et al. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation. EJNMMI Res. 2023. PMID: 36692682. doi:10.1186/s13550-023-00952-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。